Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
BAC = (1.8 x 5.14) / (180 x 0.73) - (0.015 x 2) = 9.252 / 131.4 - 0.03 = 0.0704 - 0.03 = 0.040%
All products are distributed in lyophilised format with batch-verified purity documentation
Gray-Market Distribution As an unapproved compound, 5-Amino-1MQ is largely distributed through the "gray market" research-chemical vendors rather than pharmaceutical firms, typically labelled for research use only
weight loss (Phase 2/3 peak) | ~15% | ~22% | ~24% | | FDA Status | Approved (Wegovy, Ozempic) | Approved (Zepbound, Mounjaro) | Phase 3 (2026) | | Dosing frequency | Weekly | Weekly | Weekly | The additional glucagon receptor agonism is believed to be responsible for retatrutide's greater metabolic rate increase and enhanced fat oxidation compared to dual agonists
Do not shake vials vigorously
US$ 24.63
US$ 28.51
US$ 20.05
US$ 29.40
US$ 24.95
US$ 28.53
US$ 20.28
